Chromatin Remodelling and Immunity

Chromatin Remodelling and Immunity, Volume 106, the latest release in the Advances in Protein Chemistry and Structural Biology series is an essential resource for protein chemists. Each volume brings forth new information about protocols and analysis of proteins, with each thematically organized volume guest edited by leading experts in a broad range of protein-related topics. Les mer
Vår pris
2126,-

(Innbundet) Fri frakt!
Leveringstid: Sendes innen 21 dager

Innbundet
Legg i
Innbundet
Legg i
Vår pris: 2126,-

(Innbundet) Fri frakt!
Leveringstid: Sendes innen 21 dager

Om boka

Chromatin Remodelling and Immunity, Volume 106, the latest release in the Advances in Protein Chemistry and Structural Biology series is an essential resource for protein chemists. Each volume brings forth new information about protocols and analysis of proteins, with each thematically organized volume guest edited by leading experts in a broad range of protein-related topics.

Fakta

Innholdsfortegnelse

1. Chromatin Remodeling in Monocyte and Macrophage Activation J.L. Schultze 2. Roles of SMC Complexes During T Lymphocyte Development and Function J.S. Rawlings 3. The Role of Epigenetic Regulation in Transcriptional Memory in the Immune System A.M. Woodworth and A.F. Holloway 4. Histone Acetylation and the Regulation of Major Histocompatibility Class II Gene Expression K. Suzuki and Y. Luo 5. Mechanisms of Chromatin Remodeling and Repurposing During Extracellular Translocation D.S. Pisetsky 6. Epigenetic Changes in Chronic Inflammatory Diseases O. Fogel, C. Richard-Miceli and J. Tost 7. Regulation of Cellular Immune Responses in Sepsis by Histone Modifications W.F. Carson IV and S.L. Kunkel 8. A New Molecular Mechanism Underlying the Anti-Tumor Effect of DNA Methylation Inhibitors Via an Anti-Viral Immune Response Y. Saito, T. Nakaoka and H. Saito 9. Chromatin Remodeling and Plant Immunity W. Chen, Q. Zhu, Y. Liu and Q. Zhang

Om forfatteren

Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2007 he was awarded a New Investigator Grant Award from the Medical Research Council (UK) to establish himself as an independent Principle Investigator. In 2010 Dr. Donev was appointed Senior Lecturer at Swansea University. In 2016 Dr. Donev joined MicroPharm Ltd (UK) where currently he is Head of Research. He has published more than 60 research papers, chaired scientific meetings and given invited plenary talks. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals. His research interests include signaling pathways involved in neuropsychiatric disorders and tumor escape from the immune system, and development of therapeutic strategies for their treatment. More recently he has focused on development of immunotherapeutics for non-systemic applications.